Viewing Company Equitable Group | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Equitable Group Stock Symbol: EQB-T

Last Price Recorded: $58.0800 on 2017-10-20

Globe 5 day average
Google Discussions (view only)
yahoo discussion
Bloomberg
Date Signal Expert Opinion Price
2017-09-25 BUY on WEAKNESS Stephen Takacsy, B. Eng, MBA

It has been thriving.  It is an extremely well managed and well capitalized company.  Their business is growing dramatically.  Buy it whenever it is below book value.


Price:
$55.450
Subject:
CANADIAN
Bias:
BULLISH on CANADIAN MARKET
Owned:
Yes
2017-07-21 COMMENT Ross Healy

There is nothing wrong with this company’s balance sheet. The overwhelming problem with the group was the issue of whether lenders, the people who bought the GICs, etc., wouldn’t freak out and panic when some of the US hedge funds started Shorting.


Price:
$54.100
Subject:
NORTH AMERICAN - LARGE
Bias:
UNKNOWN
Owned:
Unknown
2017-06-27 PAST TOP PICK Lyle Stein

(A Top Pick July 5/16. Up 14.74%.) The whole alternative lending sector took big tumbles on the Home Capital (HCG-T) situation. This is in a much better shape in this group.


Price:
$60.950
Subject:
CANADIAN
Bias:
UNKNOWN
Owned:
Yes
2017-06-26 TOP PICK Stephen Takacsy, B. Eng, MBA

It was caught up in the HCG-T issues.  The short sellers started pouncing on these players.  They secured loans at very low interest rates.  They pre-empted potential contagion in the industry. They are getting so much new business that they can cherry pick their new customers.  It is trading just above book.  (Analysts’ target: $62.00).


Price:
$61.910
Subject:
CANADIAN
Bias:
SELECTIVE
Owned:
Yes
2017-05-15 WATCH Bruce Campbell (1)

When he asks about buying Home Capital (HCG-T), he gets “Buy Equitable”, which is way safer and has financial backing. It doesn’t do alternative lending, but does kind of niche lending. Home Capital’s problems are going to blow over, but even if it doesn’t, that is not going to come to this company. Wait for the next Home Capital headline, and then when this drops to $45, then you have more of a ramp to do something.


Price:
$51.080
Subject:
CANADIAN LARGE
Bias:
OPTIMISTIC
Owned:
Unknown
2017-05-09 PAST TOP PICK Lyle Stein

(A Top Pick July 5/16. Down 15%.) Believed that the model was very good. He began selling it at $60, and by the time he was done it was trading at a little above $48-$49.


Price:
$48.370
Subject:
CANADIAN
Bias:
CAUTIOUS
Owned:
No
2017-05-01 HOLD Norman Levine

It is a quality company.  They have an impeccable portfolio.  Their bad loans are miniscule.  They got thrown in with HCG-T.  He can’t say anything bad about it.  Their earnings were fine when they came out.  He does not think the latest budget will have any effect on them.


Price:
$47.350
Subject:
NORTH AMERICAN - LARGE
Bias:
CAUTIOUS
Owned:
No
2017-05-01 COMMENT Paul Harris, CFA

Very similar to Home Capital (HCG-T) in how they run things. The issue a lot of these companies face is that they are borrowing money at a retail level, which has hurt them a fair bit. Everybody worries about the mortgages, but those are probably fine. The problem is, they have to be funded and the funding is the bad part. If somebody doesn’t trust you when you are funding things, it becomes very difficult. That is exactly what happened in the US in 2008. (CEO just stated that there was no material decline in deposits, and they have just lined up a $2 billion standby credit facility, just in case.)


Price:
$47.350
Subject:
GLOBAL
Bias:
OPTIMISTIC
Owned:
Unknown
2017-04-28 COMMENT Michael Sprung

Assuming that the contagion is not so devastating, and assuming that they can still raise capital at a reasonable cost, he thinks this company will pull through. A year from now, many of these companies will regain their losses.


Price:
$37.580
Subject:
CANADIAN LARGE
Bias:
UNKNOWN
Owned:
Unknown
2016-07-07 PAST TOP PICK David Baskin

(A Top Pick July 2/15. Down 12.9%.) An alternative mortgage lender. A segment that people love to hate at the moment. There is concern that the housing market, particularly in Toronto and Vancouver, are going to explode and that mortgage lenders are going to be like the ones in the US, left for dead on the battlefield. A terrific opportunity to buy a quality company.


Price:
$53.650
Subject:
NORTH AMERICAN - LARGE
Bias:
UNKNOWN
Owned:
Yes
2016-07-05 TOP PICK Lyle Stein

Mortgages. They also have a fin Tech spin to them. The fin Tech bank can get deposits that others can’t. Trading at a very low multiple, at about 7X this year’s earnings and 6X next year’s earnings. Dividend yield of 1.53%.


Price:
$54.990
Subject:
CANADIAN
Bias:
UNKNOWN
Owned:
Yes
2016-04-26 DON'T BUY Jerome Hass

Had launched a bank, and got quite a bit of attention in January when they had a savings account that was paying 3%. It was remarkably successful, and probably more than they had anticipated. Since then it has scaled back to about 2.25%. If you are lending in mortgages and paying 3% on deposits, that is going to have a real squeeze on your net interest margin. On top of that, they did a fair amount of marketing and advertising in Q1, which may have an impact on their Q1 numbers. Also, have about an 8% exposure in Alberta.


Price:
$58.840
Subject:
CANADIAN MID-CAPS & LONG/SHORT STRATEGIES
Bias:
UNKNOWN
Owned:
No
2015-10-27 TOP PICK Don Lato

This got tarnished with the Home Capital (HCG-T) brush. The big decline that occurred in the spring and summer was partly due to Home Capital. He has a lot more confidence in their due diligence that they do on their lenders and the systems they have set up. Trading at 1.2X BV and 1.5X earnings.


Price:
$54.880
Subject:
NORTH AMERICAN
Bias:
UNKNOWN
Owned:
Yes
2015-07-02 TOP PICK David Baskin

Mortgage lending to those without a T4 slip like contractors and the self-employed.  It is a prudent lender.  Loan losses are minimal as they have great credit judgment.  8 times earnings and pretty good growth rate.  The dividend is half of the banks, however.


Price:
$62.500
Subject:
NORTH AMERICAN - LARGE
Bias:
SELECTIVE
Owned:
Yes
2014-12-30 DON'T BUY Jerome Hass

Despite its size, this stock is quite illiquid and doesn’t trade very much. One of his concerns is that they have a lot more exposure to Western Canada then some of its peers. Has also had outperformance this year and its valuations are lofty relative to its peers.


Price:
$65.600
Subject:
CANADIAN MID-LARGE & SHORT-LONG STRATEGIES
Bias:
UNKNOWN
Owned:
No
Showing 1 to 15 of 28 entries
<< < 1 2 > >>

No Comments.


You must be logged in to comment.